Showing 961 - 980 results of 112,688 for search '(( 12 we decrease ) OR ( 5 ((((step decrease) OR (greater decrease))) OR (a decrease)) ))', query time: 1.16s Refine Results
  1. 961
  2. 962
  3. 963
  4. 964

    Variants encoding a restricted carboxy-terminal domain of <i>SLC12A2</i> cause hereditary hearing loss in humans by Hideki Mutai (723246)

    Published 2020
    “…Using whole-exome analysis of three families with congenital, severe-to-profound hearing loss, we identified a missense variant of <i>SLC12A2</i> in five affected members of one family showing a dominant inheritance mode, along with <i>de novo</i> splice-site and missense variants of <i>SLC12A2</i> in two sporadic cases, as promising candidates associated with hearing loss. …”
  5. 965
  6. 966
  7. 967

    Validation of a New Scoring Scale for Behavioral Assessment of L‑Dopa-Induced Dyskinesia in the Rat: A New Tool for Early Decision-Making in Drug Development by Simon Loiodice (4715610)

    Published 2017
    “…The rating scale was sensitive enough to highlight a dose-dependent amantadine-mediated decrease (about 2.2-fold) in LID score. …”
  8. 968

    S1 Data - by Toru Hosokawa (364158)

    Published 2023
    “…The bicaudate ratio increased in 38/58 (65.5%) patients, Evans index increased in 35/58 (60.3%) patients, and brain volume by volumetry decreased in 46/58 (79.3%) patients from the first to the second measurement, with significant increases in the bicaudate ratio (<i>P</i> < 0.0001) and Evans index (<i>P</i> = 0.0005) and a significant decrease in the brain volume by volumetry (<i>P</i> < 0.0001). …”
  9. 969
  10. 970
  11. 971

    Administration of APB5, but not APA5, decreases the hyperplasia of alveolar type 2 epithelial cells induced by BLM. by Masami Kishi (6167105)

    Published 2018
    “…The administration of APB5 markedly decreased the hyperplasia of type 2 epithelial cells induced by BLM. …”
  12. 972
  13. 973
  14. 974
  15. 975
  16. 976

    Attenuation of spheroid size decrease or MUC5AC increase by hit compounds. by Pranjali Beri (14945400)

    Published 2023
    “…<p>Final hit compounds (with hit concentration and corresponding target) that <b>A)</b> increased bronchosphere size compared to DMSO + 3% CSE control bronchospheres or <b>B)</b> decreased secreted MUC5AC. …”
  17. 977

    Drugs which cluster on the 'anxiolytic' group decrease 5-HT turnover in the brain. by Caio Maximino (100467)

    Published 2014
    “…<p>(A) Turnover rates, as measured by 5-HIAA:5-HT ratios, normalized to the values of vehicle-treated animals, for the following drugs: fluoxetine (FLX; chronic treatment with 10 mg/kg); chlordiazepoxide (CDZ; 0.02 mg/kg); clonazepam (CLZ; 0.05 mg/kg); diazepam (DZP; 1.25 mg/kg); buspirone (BUS; 50 mg/kg); ethanol (EtOH, 2.5%); dizocilpine (MK; 0.005 mg/kg); verapamil (VER; 5 mg/kg); WAY 100,635 (WAY; 0.03 mg/kg); and SB 224,289 (SB; 2.5 mg/kg). …”
  18. 978
  19. 979

    Nimodipine does not decrease markers of neuritic dystrophy in 5XFAD transgenic mice. by Katherine R. Sadleir (12035242)

    Published 2022
    “…<p><b>(</b>A and F) Representative immunoblots of hippocampal (A) and cortical (F) lysates of non-transgenic and 5XFAD mice treated with vehicle or nimodipine. …”
  20. 980

    Schematic drawing of IAPV (A) and ERCC (B). by Denis Witham (12517162)

    Published 2025
    “…PaCO2 reduced after 20 minutes with both techniques (IAPV: from 65 to 52 mmHg, p < 0.01, relative effect (CI) 0.15 (0.01–0.28); ERCC: from 61 to 51 mmHg, p= < 0.01, relative effect (CI) 0.22 (0.07–0.37)). A transient decrease in oxygenation was fully and rapidly reversible. …”